Literature DB >> 16790721

Survival probability in ataxia telangiectasia.

T O Crawford1, R L Skolasky, R Fernandez, K J Rosquist, H M Lederman.   

Abstract

Ataxia telangiectasia is a rare, multiorgan neurodegenerative disorder with enhanced vulnerability to cancer and infection. Median survival in two large cohorts of patients with this disease, one prospective and one retrospective, is 25 and 19 years, with a wide range. Life expectancy does not correlate well with severity of neurological impairment.

Entities:  

Mesh:

Year:  2006        PMID: 16790721      PMCID: PMC2082822          DOI: 10.1136/adc.2006.094268

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  2 in total

1.  Consequences of the delayed diagnosis of ataxia-telangiectasia.

Authors:  M D Cabana; T O Crawford; J A Winkelstein; J R Christensen; H M Lederman
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124

2.  Mortality and cancer incidence in 263 patients with ataxia-telangiectasia.

Authors:  D Morrell; E Cromartie; M Swift
Journal:  J Natl Cancer Inst       Date:  1986-07       Impact factor: 13.506

  2 in total
  37 in total

1.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

2.  Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia.

Authors:  Maureen A Lefton-Greif; Thomas O Crawford; Sharon McGrath-Morrow; Kathryn A Carson; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2011-05-15       Impact factor: 4.123

3.  Immune deficiency in Ataxia-Telangiectasia: a longitudinal study of 44 patients.

Authors:  C Chopra; G Davies; M Taylor; M Anderson; S Bainbridge; P Tighe; E M McDermott
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  Ataxia telangiectasia mutated kinase controls chronic gammaherpesvirus infection.

Authors:  Joseph M Kulinski; Steven M Leonardo; Bryan C Mounce; Laurent Malherbe; Stephen B Gauld; Vera L Tarakanova
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 5.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

6.  Cutaneous granulomatosis and combined immunodeficiency revealing Ataxia-Telangiectasia: a case report.

Authors:  Laura Folgori; Alessia Scarselli; Giulia Angelino; Francesca Ferrari; Antonio Antoccia; Luciana Chessa; Andrea Finocchi
Journal:  Ital J Pediatr       Date:  2010-04-11       Impact factor: 2.638

7.  Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan.

Authors:  Tomohiro Morio; Naomi Takahashi; Fumiaki Watanabe; Fumiko Honda; Masaki Sato; Masatoshi Takagi; Ken-Ichi Imadome; Toshio Miyawaki; Domenico Delia; Kotoka Nakamura; Richard A Gatti; Shuki Mizutani
Journal:  Int J Hematol       Date:  2009-08-25       Impact factor: 2.490

8.  Ataxia telangiectasia associated with nodular regenerative hyperplasia.

Authors:  Ki L Milligan; Karen Schirm; Stephanie Leonard; Ashleigh A Hussey; Anahita Agharahimi; David E Kleiner; Ivan Fuss; Shilpa Lingala; Theo Heller; Sergio D Rosenzweig
Journal:  J Clin Immunol       Date:  2016-09-26       Impact factor: 8.317

9.  Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice.

Authors:  Ramune Reliene; Sheila M Fleming; Marie-Françoise Chesselet; Robert H Schiestl
Journal:  Food Chem Toxicol       Date:  2007-08-29       Impact factor: 6.023

10.  Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Authors:  Rachel Warren; William Domm; Min Yee; Andrew Campbell; Jane Malone; Terry Wright; Margot Mayer-Pröschel; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.